Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 225,100 | 504,500 | 282,800 | 255,600 | 224,800 |
| Marketable Securities | 8,900 | 10,300 | 11,100 | 10,300 | 11,300 |
| Receivables | 824,300 | 532,700 | 560,900 | 523,100 | 502,100 |
| Inventories | 627,800 | 592,300 | 631,000 | 673,100 | 699,300 |
| Income taxes - deferred | 181,200 | 175,200 | 166,700 | 142,200 | 135,800 |
| TOTAL | $2,005,400 | $1,936,800 | $1,786,700 | $1,764,200 | $1,757,100 |
| Non-Current Assets | |||||
| PPE Net | 690,000 | 626,700 | 642,300 | 648,900 | 652,200 |
| Investments And Advances | 72,100 | 74,000 | 84,500 | 47,900 | 54,900 |
| Intangibles | 3,694,600 | 3,140,600 | 3,160,100 | 3,218,400 | 3,124,000 |
| Other Non-Current Assets | 177,500 | 151,000 | 13,000 | 168,300 | 124,600 |
| TOTAL | $4,634,200 | $3,992,300 | $3,899,900 | $4,083,500 | $3,955,700 |
| Total Assets | $6,639,600 | $5,929,100 | $5,686,600 | $5,847,700 | $5,712,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 250,000 | N/A | N/A | 35,000 | 85,000 |
| Accounts payable and accrued liabilities | 1,066,400 | 752,100 | 741,100 | 625,000 | 592,700 |
| TOTAL | $1,366,500 | $856,300 | $808,000 | $753,700 | $754,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,024,500 | 1,020,300 | 1,016,100 | 1,162,100 | 1,158,500 |
| Deferred Revenues | 15,000 | 18,000 | 18,900 | 20,900 | 20,000 |
| aiOther Non-Current Liabilities | 233,900 | 225,000 | 248,200 | 235,300 | 207,800 |
| TOTAL | $1,799,700 | $1,702,400 | $1,596,000 | $1,874,400 | $1,823,400 |
| Total Liabilities | $3,166,200 | $2,558,700 | $2,404,000 | $2,628,100 | $2,577,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 134,129 | 126,479 | 125,827 | 125,309 | 124,876 |
| Common Shares | 400 | 400 | 400 | 400 | 400 |
| Retained earnings | 1,922,500 | 1,869,800 | 1,824,500 | 1,806,200 | 1,780,600 |
| Other shareholders' equity | 34,000 | 15,900 | -1,100 | -14,400 | -59,800 |
| TOTAL | $3,473,400 | $3,370,400 | $3,282,600 | $3,219,600 | $3,135,200 |
| Total Liabilities And Equity | $6,639,600 | $5,929,100 | $5,686,600 | $5,847,700 | $5,712,800 |